Our top pick for
Eargo, Inc is a medical devices business based in the US. Eargo shares (EAR) are listed on the NASDAQ and all prices are listed in US Dollars.
|52-week range||USD$18 - USD$76.75|
|50-day moving average||USD$62.1306|
|200-day moving average||USD$49.7626|
|Wall St. target price||USD$69|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||N/A|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|Revenue TTM||USD$69.2 million|
|Gross profit TTM||USD$47.3 million|
|Return on assets TTM||-16.77%|
|Return on equity TTM||-41.8%|
|Market capitalisation||USD$2.2 billion|
TTM: trailing 12 months
There are currently 1.5 million Eargo shares held short by investors – that's known as Eargo's "short interest". This figure is 13.4% down from 1.8 million last month.
There are a few different ways that this level of interest in shorting Eargo shares can be evaluated.
Eargo's "short interest ratio" (SIR) is the quantity of Eargo shares currently shorted divided by the average quantity of Eargo shares traded daily (recently around 319207.70833333). Eargo's SIR currently stands at 4.8. In other words for every 100,000 Eargo shares traded daily on the market, roughly 4800 shares are currently held short.
To gain some more context, you can compare Eargo's short interest ratio against those of similar companies.
However Eargo's short interest can also be evaluated against the total number of Eargo shares, or, against the total number of tradable Eargo shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Eargo's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 Eargo shares in existence, roughly 40 shares are currently held short) or 0.1339% of the tradable shares (for every 100,000 tradable Eargo shares, roughly 134 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Eargo.
Find out more about how you can short Eargo stock.
We're not expecting Eargo to pay a dividend over the next 12 months.
Eargo, Inc., a consumer-focused medical device company, develops and sells hearing aids to assist people with hearing loss in the United States. It sells its products through online stores. The company was formerly known as Aria Innovations, Inc. and changed its name to Eargo, Inc. in November 2014. Eargo, Inc. was founded in 2010 and is headquartered in San Jose, California.
Everything we know about the Reddit IPO, plus information on how to buy in.
Everything we know about the Hayward Holdings Inc IPO, plus information on how to buy in.
Everything we know about the Alignment Healthcare Inc IPO, plus information on how to buy in.
Everything we know about the Olink Holding AB (publ) IPO, plus information on how to buy in.
Everything we know about the Procore IPO, plus information on how to buy in.
Everything we know about the Navios South American Logistics Inc IPO, plus information on how to buy in.
Everything we know about the Lava Therapeutics IPO, plus information on how to buy in.
Everything we know about the Pop Culture Group Co Ltd IPO, plus information on how to buy in.
Everything we know about the Bukalapak IPO, plus information on how to buy in.
Everything we know about the Achilles Therapeutics plc IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.